Research ArticleImmunology

Cooperation between T cell receptor and Toll-like receptor 5 signaling for CD4+ T cell activation

See allHide authors and affiliations

Science Signaling  16 Apr 2019:
Vol. 12, Issue 577, eaar3641
DOI: 10.1126/scisignal.aar3641

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Costimulatory receptor mechanisms

In addition to receiving antigen-driven signals through their T cell receptors (TCRs), CD4+ T cells also require activation of the costimulatory receptor CD28 to ensure full activation. Rodríguez-Jorge et al. combined mathematical modeling of signaling by the TCR and by the pattern recognition receptor Toll-like receptor (TLR5) to predict how the two pathways could combine to induce T cell activation. Experiments then showed how the TCR and TLR5 pathways converged on the activation of critical transcriptional regulators needed for T cell activation, suggesting that TLR5 plays a role similar to that of CD28 in T cell activation.

Abstract

CD4+ T cells recognize antigens through their T cell receptors (TCRs); however, additional signals involving costimulatory receptors, for example, CD28, are required for proper T cell activation. Alternative costimulatory receptors have been proposed, including members of the Toll-like receptor (TLR) family, such as TLR5 and TLR2. To understand the molecular mechanism underlying a potential costimulatory role for TLR5, we generated detailed molecular maps and logical models for the TCR and TLR5 signaling pathways and a merged model for cross-interactions between the two pathways. Furthermore, we validated the resulting model by analyzing how T cells responded to the activation of these pathways alone or in combination, in terms of the activation of the transcriptional regulators CREB, AP-1 (c-Jun), and NF-κB (p65). Our merged model accurately predicted the experimental results, showing that the activation of TLR5 can play a similar role to that of CD28 activation with respect to AP-1, CREB, and NF-κB activation, thereby providing insights regarding the cross-regulation of these pathways in CD4+ T cells.

View Full Text